Avicena Group Inc - 02142 Cambridge, MA

Business Name: Avicena Group Inc
Categorized In: Research and Development Laboratories
Address: 1 Cambridge Center # 5, Cambridge, MA 02142
Phone Number: (617) 225-0501
Contact Person: Belinda Tsao
Website Address: avicenagroup.com
NAICS Code: 541712
SIC Code: 8731
Business Type: B2B (Business to Business)
Employee #: 1 to 4
Location Type: Branch
Annual Revenue ($): Unknown
Share This Business:
Similar Businesses: Euclides Technologies Inc - Cambridge, MA 02142
Janus Biotherapeutics Inc - Cambridge, MA 02142
Massachusetts Institute Of Technology - Cambridge, MA 02142
Panasonic Technologies Inc - Cambridge, MA 02142
Iptyx Corporation - Cambridge, MA 02142
Thermogen Hague Incorporated - Cambridge, MA 02142
Enernetics Inc - Cambridge, MA 02142
Bgi Americas Corp - Cambridge, MA 02142
Celexion LLC - Cambridge, MA 02142
Theracrine Inc - Cambridge, MA 02142
Alinea Pharmaceuticals - Cambridge, MA 02142
Aerospace Missions Corporation - Cambridge, MA 02142
Battelle Memorial Institute - Cambridge, MA 02142
Smartworlds LLC - Cambridge, MA 02142
Biogen Idec Hemophilia - Cambridge, MA 02142
Research Institute-Medicine - Cambridge, MA 02142
Verenium Corporation - Cambridge, MA 02142
Kinalco Inc - Cambridge, MA 02142
In Vivo Therapeutics Corp - Cambridge, MA 02142

Avicena Group Inc provides professional Research and Development Laboratories from its branch at the coordinates 42.362808,-71.085043.

The company offers B2B variables under the SIC code 8731 and NAICS code 541712, while making an annual revenue of Unknown and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 1 Cambridge Center # 5, Cambridge, Massachusetts 02142 or contacted through representative Belinda Tsao at (617) 225-0501.

For frequently asked questions and further inquiries about professional Research and Development Laboratories, get to know more about Avicena Group Inc through its company website at avicenagroup.com. Engage with this business on its social media platforms through on Twitter and on Facebook.